Literature DB >> 11697631

Successful treatment of rhinocerebral zygomycosis using liposomal nystatin.

L Mileshkin1, M Slavin, J F Seymour, A McKenzie.   

Abstract

We describe a case of successful treatment of rhinocerebral mucormycosis in a patient with multiple myeloma. Therapeutic strategies used included liposomal amphotericin, hyperbaric oxygen, GM-CSF and liposomal nystatin.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11697631     DOI： 10.3109/10428190109097734

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


  4 in total

1.  Liposomal nystatin in patients with invasive aspergillosis refractory to or intolerant of amphotericin B.

Authors:  Fritz Offner; Vladimir Krcmery; Marc Boogaerts; Chantal Doyen; Dan Engelhard; Patricia Ribaud; Catherine Cordonnier; Ben de Pauw; Simon Durrant; Jean-Pierre Marie; Philippe Moreau; Harry Guiot; George Samonis; Richard Sylvester; Raoul Herbrecht
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

2.  [Foudroyant rhinocerebral zygomycosis].

Authors:  H Sudhoff; M Wagner; D Theegarten; G Rong Ming; K Bremer; K-D Heimann; K Tintelnot; S Dazert
Journal:  HNO       Date:  2003-11       Impact factor: 1.284

3.  Primary mucormycosis of abdominal wall: A rare fungal infection in a immunocompetent patient.

Authors:  Sahu Tapish; Mustafa Taha; Garg Naresh; Dhamija Neeraj; K Malik Vinod
Journal:  Indian J Surg       Date:  2010-10-20       Impact factor: 0.656

Review 4.  New insights on mucormycosis and its association with the COVID-19 pandemic.

Authors:  Mona G Alshahawey; Ghadir S El-Housseiny; Noha S Elsayed; Mohammad Y Alshahrani; Lamia Mel Wakeel; Khaled M Aboshanab
Journal:  Future Sci OA       Date:  2021-12-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.